Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).
Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
The Journal Of Pathology
León-Castillo, Alicia A; Gilvazquez, Ester E; Nout, Remi R; Smit, Vincent Thbm VT; McAlpine, Jessica N JN; McConechy, Melissa M; Kommoss, Stefan S; Brucker, Sara Y SY; Carlson, Joseph W JW; Epstein, Elisabeth E; Rau, Tilman T TT; Soslow, Robert A RA; Ganesan, Raji R; Matias-Guiu, Xavier X; Oliva, Esther E; Harrison, Beth T BT; Church, David N DN; Gilks, C Blake CB; Bosse, Tjalling T
Interpretation of somatic POLE mutations in endometrial carcinoma.
The Journal Of Pathology
León-Castillo, Alicia A; Britton, Heidi H; McConechy, Melissa K MK; McAlpine, Jessica N JN; Nout, Remi R; Kommoss, Stefan S; Brucker, Sara Y SY; Carlson, Joseph W JW; Epstein, Elisabeth E; Rau, Tilman T TT; Bosse, Tjalling T; Church, David N DN; Gilks, C Blake CB
Imboden, Sara S; Nastic, Denis D; Ghaderi, Mehran M; Rydberg, Filippa F; Rau, Tilman T TT; Mueller, Michael D MD; Epstein, Elisabeth E; Carlson, Joseph W JW